Novo Nordisk has taken legal action against Eli Lilly, filing a lawsuit in a U.S. federal court alleging that the latter’s advertising for weight-loss medicines is misleading. Novo accuses Lilly of falsely comparing high doses of its drugs to lower doses of Novo’s Wegovy and Ozempic, omitting the latest clinical data.<\/p>\n
According to Novo’s complaint, the disputed advertisements have been widely disseminated, impacting the brand’s market position adversely. Novo’s reaction comes after attempts to resolve the matter with a cease-and-desist letter were unsuccessful, and Lilly continued its advertising campaign with only minor adjustments.<\/p>\n
This legal battle underscores the intense rivalry in the obesity drug market, poised to exceed $100 billion by 2030. It also raises questions about the ethics and regulations surrounding pharmaceutical advertising, particularly in markets like the U.S., where such practices directly target consumers.<\/p>\n
(With inputs from agencies.)<\/p>\n","protected":false},"excerpt":{"rendered":"Novo Nordisk has taken legal action against Eli Lilly, filing a lawsuit in a U.S. federal court alleging…\n","protected":false},"author":2,"featured_media":132938,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[15044,2042,276,64655,3846,20191,272,27569,64656,277],"class_list":["post-132937","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-clinical-trials","tag-competition","tag-eli-lilly","tag-false-advertising","tag-lawsuit","tag-legal-battle","tag-novo-nordisk","tag-obesity-market","tag-pharmaceutical-advertising","tag-weight-loss-drugs"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/116959720651839240","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/132937","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=132937"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/132937\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/132938"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=132937"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=132937"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=132937"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}